|
|
||||||||
Ann Thorac Surg 2000;70:1594-1600
© 2000 The Society of Thoracic Surgeons
a Departments of Experimental and Clinical Medicine and Biomedical Sciences, and Institute of Cardiovascular Surgery, University of Padua, and Fidia Research Laboratories, Padua, Italy
Address reprint requests to Dr Pauletto, Department of Experimental and Clinical Medicine, University of Padua, Via Giustiniani, 2-35128 Padua, Italy
e-mail: pauletto{at}ux1.unipd.it
Background. Cell populations present in human semilunar valves have not been investigated thoroughly. The aim of this study was to characterize the cell phenotypes in pulmonary valve leaflets (PVL) in comparison with aortic (AVL) valve leaflets.
Methods. AVL and PVL were dissected from hearts (n = 4) harvested from transplanted patients. Leaflets were processed for immunocytochemistry analysis and Western blotting procedures using a panel of monoclonal antibodies specific for cytoskeletal/contractile antigens.
Results. The fibrosa and the ventricularis layers of AVL had a higher cellularity than PVL. In PVL and AVL most cells were reactive for vimentin and nonmuscle (NM) myosin, though vimentin-positive cells were more abundant in AVL than in PVL. Sparse cells positive to antismooth muscle (SM)
-actin, calponin, and anti-SM myosin antibodies were found only at the outer edge of fibrosa. In Western blotting, AVL and PVL extracts were shown to be equally reactive for vimentin, SM
-actin, and NM myosin, whereas both valves were negative for SM myosin and SM22.
Conclusions. Three distinct cell phenotypes have been identified in both valves: fibroblasts, myofibroblasts, and fetal-type SM cells whose distribution is specifically related to the valve layers. Although PVL and AVL cell populations differ quantitatively, some minor qualitative differences exist for vimentin and NM myosin distribution. These data are essential for studies aimed at repopulating valve scaffolds by using tissue engineering technology.
This article has been cited by other articles:
![]() |
X. Yang, D. A. Fullerton, X. Su, L. Ao, J. C. Cleveland Jr, and X. Meng Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J. Am. Coll. Cardiol., February 10, 2009; 53(6): 491 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scharfschwerdt, H.-H. Sievers, M. von Heinz, and C. Schmidtke Vena cava as autologous tissue for pulmonary valve substitute Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 973 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pho, W. Lee, D. R. Watt, C. Laschinger, C. A. Simmons, and C. A. McCulloch Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1767 - H1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Meng, L. Ao, Y. Song, A. Babu, X. Yang, M. Wang, M. J. Weyant, C. A. Dinarello, J. C. Cleveland Jr., and D. A. Fullerton Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis Am J Physiol Cell Physiol, January 1, 2008; 294(1): C29 - C35. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H Chester and P. M Taylor Molecular and functional characteristics of heart-valve interstitial cells Phil Trans R Soc B, August 29, 2007; 362(1484): 1437 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. Sievers In vivo tissue engineering an autologous semilunar biovalve: Can we get what we want? J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 20 - 22. [Full Text] [PDF] |
||||
![]() |
G. De Visscher, I. Vranken, A. Lebacq, C. Van Kerrebroeck, J. Ganame, E. Verbeken, and W. Flameng In vivo cellularization of a cross-linked matrix by intraperitoneal implantation: a new tool in heart valve tissue engineering Eur. Heart J., June 1, 2007; 28(11): 1389 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Vesely Heart Valve Tissue Engineering Circ. Res., October 14, 2005; 97(8): 743 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W.H. Sutherland, T. E. Perry, Y. Yu, M. C. Sherwood, E. Rabkin, Y. Masuda, G. A. Garcia, D. L. McLellan, G. C. Engelmayr Jr, M. S. Sacks, et al. From Stem Cells to Viable Autologous Semilunar Heart Valve Circulation, May 31, 2005; 111(21): 2783 - 2791. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Walker, K. S. Masters, D. N. Shah, K. S. Anseth, and L. A. Leinwand Valvular Myofibroblast Activation by Transforming Growth Factor-{beta}: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease Circ. Res., August 6, 2004; 95(3): 253 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Messner, C. Vatcharasiritham, I. Gregoric, B. Radovancevic, P. Odegaard, S. D. Flamm, and O. H. Frazier Prosthetic graft remnant-related pseudoaneurysm after left ventricular assist device explantation: A case report J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 259 - 261. [Full Text] [PDF] |
||||
![]() |
B. Bertipaglia, F. Ortolani, L. Petrelli, G. Gerosa, M. Spina, P. Pauletto, D. Casarotto, M. Marchini, and S. Sartore Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur) Ann. Thorac. Surg., April 1, 2003; 75(4): 1274 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Weind, D. R. Boughner, L. Rigutto, and C. G. Ellis Oxygen diffusion and consumption of aortic valve cusps Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2604 - H2611. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |